Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control … (NCT06751030) | Clinical Trial Compass
RecruitingNot Applicable
Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria
Nigeria1,500 participantsStarted 2024-12-03
Plain-language summary
The goal of this observational study is to focus on adapting and implementing a program to promote HPV and cervical cancer (CC) screening and follow-up treatment for HIV-positive women, with three specific aims:
* Adaptation: Use stakeholder deliberation to tailor the successful MoMent program for this population.
* Implementation and Assessment: Deploy the adapted MoMent program and evaluate its reach, effectiveness, adoption, and fidelity.
* Evaluation: Conduct a post-implementation process evaluation to identify barriers and facilitators to the program's maintenance and sustainability.
Who can participate
Age range
25 Years – 50 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
\- Patients must be able to perform vaginal self-collection as well as give informed consent
Exclusion Criteria:
* Male gender
* Age \<25 or \>50
* Unknown or negative HIV status
* Pregnancy
* Hysterectomy
* Inability to give informed consent Inability/refusal to perform vaginal self-collection
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is focused on delivering cervical cancer screening services to HIV-positive women through community and home-based education in Nigeria — does my current situation and location make this something worth exploring with my care team?
2Since this trial is measuring how well the program reaches women and whether it gets adopted by communities rather than testing a new drug or medical procedure, what would my actual participation look like day-to-day, and what would be asked of me?
3The study is tracking 'fidelity of the program,' meaning how consistently the education and screening services are delivered — how would my doctor know whether I'm receiving the full, consistent level of care the trial is designed to provide?
4Because this is a Phase NA implementation science study rather than a drug trial, does it change how I should think about the risks compared to just accessing standard cervical cancer screening outside of a trial?
5Given that this trial is specifically designed for HIV-positive women and focuses on increasing access to cervical cancer screening, would my doctor recommend I pursue standard cervical cancer screening first, or could this trial offer access I might not otherwise have?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.